| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6029e22b6df62b0e683d354f210770f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a70b05f3bdf7f6e9aaf7a41ac3aacdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a1ebe5699c0f911c0aa606bf0d1b141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ffb4d9ab2be1ea9ad272b940a8d61de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73d63812ed2e781020a222afb2cd030b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a307dc569fba2d70148ab0a38513b6d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2004-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ac427a0059a374c0f8110aa338e952d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ff2f785c2cfb26d69e37847c114f51a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21a1083dad9afd91a4c6ba98d74b149b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c0114ed9ac749603ccb51d726ef15ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d76dd4319dadf1e52d5b516396a213 |
| publicationDate |
2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004092413-A2 |
| titleOfInvention |
High throughput functional genomic screening methods for osteoarthritis |
| abstract |
High-throughput functional screening assays are provided that identify genes and gene products that are associated with the pathogenesis of osteoarthritis (OA) in chondrocytes. In addition, genes and gene products identified by such functional assays are also provided. The genes and gene products provided herein are useful inter alia for diagnosing OA in individuals and as drug targets for identifying drugs to treat OA. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008079877-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8224579-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005121778-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006010498-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1774029-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010071405-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008079877-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1774029-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006010498-A2 |
| priorityDate |
2003-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |